Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Dermatologic ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.Dermatol Clin. 2015; 33: 643-654https://doi.org/10.1016/j.det.2015.06.001
- NCCN Guidelines, Primary Cutaneous Lymphomas.(Available at:) (Accessed February 2, 2022)
- The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.Blood. 2019; 133https://doi.org/10.1182/blood-2018-11-881268
- SEER Database on Mycosis Fungoides.(Available at:) (Accessed February 2, 2022)
- Mycosis Fungoides Variants.Surg Pathol Clin. 2014; 7: 169-189https://doi.org/10.1016/j.path.2014.02.003
- Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors.Pathology. 2014; 46https://doi.org/10.1097/PAT.0000000000000166
- T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides.J Am Acad Dermatol. 2007; 57: 782-790https://doi.org/10.1016/j.jaad.2007.06.004
- Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management.Am J Hematol. 2019; 94: 1027-1041https://doi.org/10.1002/ajh.25577
- How to Sequence Therapies in Mycosis Fungoides.Curr Treat Options Oncol. 2021; 22: 101https://doi.org/10.1007/s11864-021-00899-0
- Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy.Curr Treat Options Oncol. 2021; 22: 10https://doi.org/10.1007/s11864-020-00809-w
- Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium.J Am Acad Dermatol. 2016; 74: 27-58https://doi.org/10.1016/j.jaad.2015.09.033
- Skin-directed radiation therapy for cutaneous lymphoma: The Mayo Clinic experience.J Am Acad Dermatol. 2020; 82: 634-641https://doi.org/10.1016/j.jaad.2019.07.040
- A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life.J Am Acad Dermatol. 2020; 83: 78-85https://doi.org/10.1016/j.jaad.2020.01.046
- Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome.Curr Oncol Rep. 2018; 20: 32https://doi.org/10.1007/s11912-018-0678-x
- Prognostic Factors, Staging and Treatments in Advanced Stage Mycosis Fungoides and Sézary Syndrome.Blood. 2014; 124: 1673https://doi.org/10.1182/blood.V124.21.1673.1673
- Racial disparity in mycosis fungoides: An analysis of 4495 cases from the US National Cancer Database.J Am Acad Dermatol. 2017; 77: 497-502.e2https://doi.org/10.1016/j.jaad.2017.04.1137
- Pruritus in cutaneous T-cell lymphoma: A review.J Am Acad Dermatol. 2012; 67: 760-768https://doi.org/10.1016/j.jaad.2011.12.021
- WHO-EORTC classification for cutaneous lymphomas.Blood. 2005; 105https://doi.org/10.1182/blood-2004-09-3502
- Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign--histologically malignant.Arch Dermatol. 1968; 97https://doi.org/10.1001/archderm.97.1.23
- Lymphomatoid papulosis: an update and review.J Eur Acad Dermatol Venereol. 2020; 34https://doi.org/10.1111/jdv.15931
- Lymphomatoid Papulosis and Other Lymphoma-Like Diseases.Dermatol Clin. 2019; 37https://doi.org/10.1016/j.det.2019.05.005
- Lymphomatoid Papulosis in Children and Adolescents: A Systematic Review.Am J Clin Dermatol. 2016; 17: 319-327https://doi.org/10.1007/s40257-016-0192-6
- Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid Papulosis.Oncologist. 2016; 21: 76-83https://doi.org/10.1634/theoncologist.2015-0242
- Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosis.J Eur Acad Dermatol Venereol. 2020; 34: 260-266https://doi.org/10.1111/jdv.16065
- Primary cutaneous T-cell lymphomas other than Mycosis Fungoides and Sezary Syndrome – Part II: Prognosis and Management.J Am Acad Dermatol. 2021; (Published online)https://doi.org/10.1016/j.jaad.2021.04.081
- ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient.J Cutan Pathol. 2015; 42https://doi.org/10.1111/cup.12446
- Primary cutaneous anaplastic large cell lymphoma.J Cutan Pathol. 2017; 44https://doi.org/10.1111/cup.12937
- EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.Blood. 2011; 118https://doi.org/10.1182/blood-2011-05-351346
- Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma.J Eur Acad Dermatol Venereol. 2020; 34: 762-768https://doi.org/10.1111/jdv.16006
- Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.Am J Surg Pathol. 2012; 36https://doi.org/10.1097/PAS.0b013e3182487158
- Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.Mod Pathol. 2011; 24: 596-605https://doi.org/10.1038/modpathol.2010.225
- ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.Blood. 2014; 124: 1473-1480https://doi.org/10.1182/blood-2014-04-571091
- IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases.J Invest Dermatol. 2010; 130https://doi.org/10.1038/jid.2009.314
- T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome.Am J Surg Pathol. 1991; 15: 17-27https://doi.org/10.1097/00000478-199101000-00002
- Epidemiology of primary cutaneous γδ T-cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma in the U.S.A. from 2006 to 2015: a Surveillance, Epidemiology, and End Results-18 analysis.Br J Dermatol. 2019; 181: 848-850https://doi.org/10.1111/bjd.17985
- Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases.Blood. 2008; 111https://doi.org/10.1182/blood-2007-04-087288
- Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patients.J Am Acad Dermatol. 2018; 79https://doi.org/10.1016/j.jaad.2018.05.1243
- WHO classification of tumours of haematopoietic and lymphoid tissues.WHO Press, 2008
- Clinicopathological analysis of 17 primary cutaneous T-cell lymphoma of the γδ phenotype from Japan.Cancer Sci. 2014; 105https://doi.org/10.1111/cas.12439
- TCR-γ expression in primary cutaneous T-cell lymphomas.Am J Surg Pathol. 2013; 37https://doi.org/10.1097/PAS.0b013e318275d1a2
- Gamma-delta t-cell lymphomas.Eur J Haematol. 2015; 94https://doi.org/10.1111/ejh.12439
- Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas.Nat Commun. 2020; 11: 1806https://doi.org/10.1038/s41467-020-15572-7
- The significance of epidermal involvement in primary cutaneous gamma/delta (γδ) T-cell lymphoma: A systematic review and meta-analysis.J Cutan Pathol. 2021; 48: 1449-1454https://doi.org/10.1111/cup.14082
- Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma.Blood. 2003; 101: 3407-3412https://doi.org/10.1182/blood-2002-05-1597
- Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.Nat Commun. 2015; 6https://doi.org/10.1038/ncomms7025
- Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell Lymphomas.Am J Surg Pathol. 2017; 41: 204-215https://doi.org/10.1097/PAS.0000000000000768
- Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.Blood. 2018; 131https://doi.org/10.1182/blood-2017-12-791418
- Management of NK/T-Cell Lymphoma, Nasal Type.J Oncol Pract. 2019; 15https://doi.org/10.1200/JOP.18.00719
- Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.Curr Hematol Malig Rep. 2016; 11https://doi.org/10.1007/s11899-016-0355-9
- NK/T-cell lymphomas.Best Pract Res Clin Haematol. 2019; 32: 253-261https://doi.org/10.1016/j.beha.2019.06.005
- EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults.Am J Surg Pathol. 2010; 34https://doi.org/10.1097/PAS.0b013e3181fbb4fd
- Extranodal NK/T cell lymphoma, nasal type WHO classification of tumours of haematopoietic and lymphoid Tissues.International Agency for Research on Cancer, 2017: 368-371
- NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.J Natl Compr Canc Netw. 2018; 16: 123-135https://doi.org/10.6004/jnccn.2018.0007
- Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group.Bone Marrow Transpl. 2014; 49: 902-906https://doi.org/10.1038/bmt.2014.65
- Localization patterns and survival of extranodal natural killer/T-cell lymphomas in the United States: A population-based study of 945 cases.J Am Acad Dermatol. 2021; 85: 1318-1321https://doi.org/10.1016/j.jaad.2020.08.109
- Cutaneous peripheral T-cell lymphoma, not otherwise specified: A single-center prognostic analysis.J Am Acad Dermatol. 2016; 75https://doi.org/10.1016/j.jaad.2016.06.011
- Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features.J Eur Acad Dermatol Venereol. 2021; 35https://doi.org/10.1111/jdv.16969
- Post-transplant primary cutaneous peripheral T-cell lymphoma not otherwise specified in a pediatric patient.J Cutan Pathol. 2021; 48https://doi.org/10.1111/cup.13967
- Cutaneous T Cell Lymphoma: A Difficult Diagnosis Demystified.Dermatol Clin. 2019; 37https://doi.org/10.1016/j.det.2019.05.007
- Primary cutaneous follicular variant of peripheral T-cell lymphoma NOS. A report of two cases.Histopathology. 2010; 56https://doi.org/10.1111/j.1365-2559.2010.03498.x
- Adult T-cell leukemia: clinical and hematologic features of 16 cases.Blood. 1977; 50: 481-492
- Improved survival for skin-primary presentation of adult T-cell leukemia/lymphoma (ATLL).J Am Acad Dermatol. 2020; 83https://doi.org/10.1016/j.jaad.2019.11.034
- Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma.Blood. 2011; 117https://doi.org/10.1182/blood-2010-11-316794
- Cutaneous manifestations of adult T-cell leukemia/lymphoma.Semin Diagn Pathol. 2020; 37https://doi.org/10.1053/j.semdp.2019.07.010
- Adult T-cell leukemia/lymphoma clinically confused with viral/drug skin eruptions and pathologically misinterpreted as mycosis fungoides/Sézary syndrome.J Cutan Pathol. 2021; 48https://doi.org/10.1111/cup.13789
- How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?.Curr Opin Virol. 2015; 14: 93-100https://doi.org/10.1016/j.coviro.2015.09.004
- Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective study.J Am Acad Dermatol. 2015; 72: 293-301https://doi.org/10.1016/j.jaad.2014.10.006
- Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002.J Clin Oncol. 2016; 34https://doi.org/10.1200/JCO.2016.67.7732
- Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).Blood. 2009; 113https://doi.org/10.1182/blood-2009-03-211821
- Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.J Clin Oncol. 2019; 37: 677-687https://doi.org/10.1200/JCO.18.00501
- An Update on Molecular Biology of Cutaneous T Cell Lymphoma.Front Oncol. 2019; 9: 1558https://doi.org/10.3389/fonc.2019.01558
- Genomic landscape of cutaneous T cell lymphoma.Nat Genet. 2015; 47: 1011-1019https://doi.org/10.1038/ng.3356
- Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.Nat Genet. 2015; 47: 1056-1060https://doi.org/10.1038/ng.3370
- Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.Haematologica. 2015; 100: e450-e453https://doi.org/10.3324/haematol.2015.132837
- New Insights Into the Complex Mutational Landscape of Sézary Syndrome.Front Oncol. 2020; 10https://doi.org/10.3389/fonc.2020.00514
- Update on Biology of Cutaneous T-Cell Lymphoma.Front Oncol. 2020; 10https://doi.org/10.3389/fonc.2020.00765
- Subcutaneous panniculitis-like T-cell lymphoma, lupus erythematosus profundus, and overlapping cases: molecular characterization through the study of 208 genes.Leuk Lymphoma. 2021; 62: 2130-2140https://doi.org/10.1080/10428194.2021.1901098
- Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.Nat Genet. 2018; 50: 1650-1657https://doi.org/10.1038/s41588-018-0251-4
- Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma.Blood Adv. 2019; 3: 588-595https://doi.org/10.1182/bloodadvances.2018028340
- HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma.Blood. 2020; 135: 1058-1061https://doi.org/10.1182/blood.2019003811
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
